Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered.

Deltenre, Pierre; Moreno, Christophe; Trépo, Eric

Deltenre, Pierre; Moreno, Christophe; Trépo, Eric.

Deltenre P; Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; Department of Gastroenterology and Hepatology, Clinique St Luc, Bouge, Belgium. Electronic address: pierre.deltenre01@gmail.com.
Moreno C; Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, Brussels, Belgium.
Trépo E; Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, CUB Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, Brussels, Belgium.

J Hepatol ; 75(4): 989-990, 2021 10.

Artículo en Inglés | MEDLINE | ID: covidwho-1141978

Asunto(s)

COVID-19; Ketamina; Humanos; Ketamina/efectos adversos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: COVID-19 / Ketamina Límite: Humanos Idioma: Inglés Revista: J Hepatol Asunto de la revista: Gastroenterologia Año: 2021 Tipo del documento: Artículo

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google